Project Details
Description
RDC-0313: Phase 2 Randomized, Double-blind, Placebo-controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults with Binge Eating Disorder
Status | Finished |
---|---|
Effective start/end date | 8/1/10 → 7/31/13 |
Funding
- ALKERMES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.